Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Perioperative Multimodal Analgesia Protocol for Supratentorial Craniotomy
NCT06406829Not yet recruiting
- Sponsor
- Beijing Tiantan Hospital
- Start
- Feb 2026
- Primary completion
- Dec 2026
- Modality
- Small Molecules
01
Overview
Randomised trial of dexmedetomidine and liposomal bupivacaine in postoperative pain (4 arms), sponsored by Beijing Tiantan Hospital. Primary endpoint: Cumulative amount of sufentanil used by patient-controlled analgesia (PCIA) at 48 hours. Planned start Feb 2026; status: not yet recruiting.
02
Drugs
dexmedetomidineliposomal bupivacaine
03
Conditions
postoperative pain
Beyond the preview
Go deeper on NCT06406829.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NCT06406829.